Replay available

MediWound Ltd. (MDWD) Q2 2025 Earnings Call

MediWound Ltd. (NASDAQ: MDWD) Q2 2025 earnings conference call, held 2025-08-14. Replay captured from the company's public earnings webcast.

Thu, August 14, 2025 at 8:30 AMendedReplay
MediWound Ltd. (MDWD) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Dan Ferry

Managing Partner, LifeSci Advisors

Ofer Gonen

Chief Executive Officer, Mediwound

Hani Luxemburg

Chief Financial Officer, Mediwound

Barry Wolfesson

EVP of Strategy and Corporate Development, Mediwound

Josh Jennings

Analyst, TD Cowen

Maya Eskandarani

Analyst, H.C. Wainwright

Michael Okudovich

Analyst, Maxim Group

Chase Knickerbocker

Analyst, Craig-Hallam

Scott Henry

Analyst, AGP

Replay transcript excerpt

Good day and welcome to Mediwound Second Quarter 2025 Earnings Conference Call. All participants will be in the listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then 1 on your touch-tone phone. To withdraw your questions, please press star then 2. Please note, this event is being recorded. I would now like to turn the conference over to Dan Ferry of LifeSciAdvisors. Please go ahead. Thank you, Operator, and welcome, everyone. Earlier today, pre-market open, MedWound issued a press release announcing financial results for the second quarter ended June 30, 2025. You may access this press release on the company's website under the Investors tab. It would ask you to review the full text of our forward-looking statements within this morning's press release. Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session, relating to anyone's expected future performance, future business prospects, or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. These statements may involve risks and uncertainties that could cause actual results to differ materially from expectations that are described more fully in our filings with the SEC. In addition, All forward-looking statements represent our views only as of today, and MetaWound assumes no obligation to update or supplement any forward-looking statements, whether a result of new information, future events, or otherwise. This conference call is the property of MetaWound, and any recording or rebroadcast is expressly pro...

More from Mediwound Ltd.